Seattle, July 18, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global cryopreservation equipment market is estimated to be valued at US$ 8,002.9 million in 2022 and is expected to exhibit a CAGR of 13.2% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Cryopreservation Equipment Market:
Major players operating in market are launching new products, which is expected to drive market growth over the forecast period. For instance, in March 2022, Stemcell Technologies Inc., a cryopreservative equipment company launched its new series of preservation solution of CryoStor. CryoStor CS10 is a uniquely formulated serum-free, animal component-free, and defined cryopreservation medium containing 10% dimethyl sulfoxide (DMSO), designed to preserve cells in low temperature environments (-80°C to -196°C). CryoStor CS10 provides a safe, protective environment for cells and tissues during the freezing and thawing processes and during storage. CryoStor CS2, CS5, and CS10 are a series of cell specific, optimized preservation media, uniquely formulated to address the molecular biological aspects of cells during the cryopreservation process, thereby, directly reducing the level of cryopreservation-induced delayed-onset cell death and improving post-thaw cell viability and function.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1356
Key Market Takeaways:
Global cryopreservation…
